Global Apixaban Prices Q2 2025: Chart, Analysis & Forecast

North America Apixaban Prices Movement Q2:

Apixaban Prices in USA:

In Q2 2025, apixaban prices in the USA reached 44,617 USD/MT in June. Prices rose steadily, supported by consistent demand for cardiovascular therapies, higher API production and compliance costs, and stable healthcare utilization. Generics moderated volatility, yet firm supply chains and sustained consumption maintained a controlled, input cost-driven price increase.

Get the Real-Time Prices Analysis: https://www.imarcgroup.com/apixaban-pricing-report/requestsample

Note: The analysis can be tailored to align with the customer's specific needs.

APAC Apixaban Prices Movement Q2:

Apixaban Prices in China:

In Q2 2025, apixaban prices in China reached 24,295 USD/MT in June. Prices rose steadily, driven by strong cardiovascular treatment demand and sustained API procurement. Limited competition among domestic manufacturers supported firm pricing, while stable supply chains persisted. Monitoring fermentation input costs added slight upward pressure, reinforcing market strength during the quarter.

Apixaban Prices in India:

In Q2 2025, apixaban prices in India reached 30,369 USD/MT in June. Prices showed moderate firmness, supported by steady cardiovascular treatment demand from hospitals and clinics. Stable supply was ensured through domestic and Chinese API sourcing. Currency fluctuations and higher formulation costs added slight upward pressure, maintaining a balanced market trend.

Apixaban Prices in Korea:

In Q2 2025, apixaban prices in Korea reached 43,946 USD/MT in June. Prices stayed stable to slightly firm, supported by strong healthcare demand and reliable supply chains. Modest pressure from emerging generics was offset by reliance on imported APIs and expanded therapeutic approvals, maintaining a resilient and balanced pricing environment.

Regional Analysis: The price analysis can be extended to provide detailed Apixaban price information for the following list of countries.
China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.

Europe Apixaban Prices Movement Q2:

Apixaban Prices in Germany:

In Q2 2025, apixaban prices in Germany reached 55,269 USD/MT by June. Prices remained firm due to stable demand, tight patent-related supply controls, and delays in generic competition. Fermentation-based API production costs and steady procurement across hospitals and pharmacies contributed to price stability, maintaining overall resilience in the pharmaceutical market.

Regional Analysis: The price analysis can be expanded to include detailed Apixaban price data for a wide range of European countries, such as Germany, France, the United Kingdom, Italy, Spain, Russia, Turkey, the Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, the Czech Republic, Portugal, and Greece, along with other European nations.

Purchase Options: https://www.imarcgroup.com/checkout?id=22910&method=1925

• Biannual Updates: For 2 Deliverables, Billed Annually
• Quarterly Updates: For 4 Deliverables, Billed Annually
• Monthly Updates: For 12 Deliverables, Billed Annually

We Also Provide News and Historical Data of Apixaban
• Historical Data: Comprehensive historical pricing and market trends.
• Quarterly Analysis: Detailed insights into price fluctuations and market dynamics.
• Regional and Global Data: Coverage of key markets and their performance.
• Forecast Comparisons: Historical data paired with future market projections.
• Customizable Reports: Tailored analysis to meet specific business needs.

Factors Affecting Apixaban Prices:

Demand-Side Factors:
• Strong demand from cardiovascular and stroke prevention therapies.
• Expanding therapeutic approvals supporting wider usage.
• Steady healthcare utilization in hospitals and specialty clinics.
Supply-Side Factors:
• Dependence on imported APIs and raw materials.
• Rising API production and formulation costs.
• Limited competition in some regions, though generics added modest pressure.

Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=22910&flag=C

Key Coverage:
• Market Analysis
• Market Breakup by Region
• Demand Supply Analysis by Type
• Demand Supply Analysis by Application
• Demand Supply Analysis of Raw Materials
• Price Analysis
o Spot Prices by Major Ports
o Price Breakup
o Price Trends by Region
o Factors influencing the Price Trends
• Market Drivers, Restraints, and Opportunities
• Competitive Landscape
• Recent Developments
• Global Event Analysis

How IMARC Pricing Database Can Help

The latest IMARC Group study, "Apixaban Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data 2025 Edition," presents a detailed analysis of Apixaban price trend, offering key insights into global Apixaban market dynamics. This report includes comprehensive price charts, which trace historical data and highlights major shifts in the market.

The analysis delves into the factors driving these trends, including raw material costs, production fluctuations, and geopolitical influences. Moreover, the report examines Apixaban demand, illustrating how consumer behaviour and industrial needs affect overall market dynamics. By exploring the intricate relationship between supply and demand, the prices report uncovers critical factors influencing current and future prices.

Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: +1-631-791-1145

About Us:
IMARC Group is a global management consulting firm that provides a comprehensive suite of services to support market entry and expansion efforts. The company offers detailed market assessments, feasibility studies, regulatory approvals and licensing support, and pricing analysis, including spot pricing and regional price trends. Its expertise spans demand-supply analysis alongside regional insights covering Asia-Pacific, Europe, North America, Latin America, and the Middle East and Africa. IMARC also specializes in competitive landscape evaluations, profiling key market players, and conducting research into market drivers, restraints, and opportunities. IMARC's data-driven approach helps businesses navigate complex markets with precision and confidence.

This release was published on openPR.